Condition
Persistent Postoperative Pain
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 80/100
Termination Rate
40.0%
2 terminated out of 5 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 3 (2)
Trial Status
Completed2
Terminated2
Recruiting1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT03216187Phase 3TerminatedPrimary
Swiss Multi-centre, Randomized, Placebo Controlled Trial of Pregabalin for Prevention of Persistent Pain in High Risk Patients Undergoing Breast Cancer Surgery
NCT06271174Phase 3RecruitingPrimary
Avoid With Locoregional Analgesia Persistant Postoperative Pain In Children
NCT01743313Terminated
Glucose Metabolism Disorders and Metabolic Syndrome Before and After Primary Hip and Knee Replacement
NCT03460028Not ApplicableCompletedPrimary
Yoga for Persistent Pain Related to Oncology Surgery
NCT04520334Not ApplicableCompleted
A Zhineng Qigong Intervention for Patients With Chronic Low Back Pain and/or Leg Pain
Showing all 5 trials